Aileron Therapeutics, Inc. (ALRN): Price and Financial Metrics
ALRN Price/Volume Stats
| Current price | $1.75 | 52-week high | $7.42 |
| Prev. close | $1.76 | 52-week low | $1.61 |
| Day low | $1.70 | Volume | 71,500 |
| Day high | $1.88 | Avg. volume | 75,366 |
| 50-day MA | $3.06 | Dividend yield | N/A |
| 200-day MA | $3.49 | Market Cap | 37.92M |
ALRN Stock Price Chart Interactive Chart >
Aileron Therapeutics, Inc. (ALRN) Company Bio
Aileron Therapeutics is a clinical-stage biopharmaceutical company advancing a novel class of therapeutics called stapled peptides, which represent the first general solution, or "scaffold" for modulating intracellular protein-protein interactions that are critical control points to nearly all functions of a cell. The company's lead product candidate ALRN-6924 is being evaluated in multiple clinical trials. The company was founded in 2005 and is based in Cambridge, Massachusetts.
ALRN Price Returns
| 1-mo | -32.17% |
| 3-mo | -53.08% |
| 6-mo | -43.18% |
| 1-year | -44.44% |
| 3-year | -84.97% |
| 5-year | -85.55% |
| YTD | -42.60% |
| 2023 | 28.63% |
| 2022 | -78.95% |
| 2021 | -45.88% |
| 2020 | 81.50% |
| 2019 | -31.79% |
Loading social stream, please wait...